Inventor
Chie Sakanaka
Inventor
Tokyo, JP
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes23%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
C07KPeptides23%
G01NInvestigating or analysing materials by determining their chemical or physical properties15%
C12NMicroorganisms or enzymes13%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests5%
PatentTitleYear
10,889,651Anti-Ly6E antibodies and methods of use202110,653,792Anti-Ly6E antibodies and immunoconjugates and methods of use202010,066,022Anti-Ly6E antibodies and methods of use20189,724,427'Anti-Ly6E antibodies and immunoconjugates and methods of use'20179,675,707'Anti-TAT226 antibodies and immunoconjugates'20179,290,578'Anti-Ly6E antibodies and methods of use'20169,109,035'Anti-TAT226 antibodies and immunoconjugates'20158,183,347'Anti-TAT226 antibodies and immunoconjugates'20127,803,915'Antibody compositions for the diagnosis and treatment of tumor'2010Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2010–2021Patents assigned to GENENTECH INC (9)· patent assignee history
2010–2017Based in San Francisco, CA, US· patent location history
2012–2015Patents assigned to LIANG WEI-CHING (2)· patent assignee history
2012–2015Patents assigned to SAKANAKA CHIE (2)· patent assignee history
2012–2015Patents assigned to WU YAN (2)· patent assignee history
2016–2021Based in Tokyo, JP· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GENENTECH INC | 9 | 2010–2021 |
| LIANG WEI-CHING | 2 | 2012–2015 |
| SAKANAKA CHIEself | 2 | 2012–2015 |
| WU YAN | 2 | 2012–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Tokyo, JP | 5 | 2016–2021 |
| San Francisco, California, US | 4 | 2010–2017 |